|
RDH14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.485000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.661800E-02 |
| Normal-vs-Stage2 |
8.401200E-01 |
| Normal-vs-Stage3 |
5.750600E-01 |
| Normal-vs-Stage4 |
7.099800E-01 |
| Stage1-vs-Stage2 |
3.612000E-01 |
| Stage1-vs-Stage3 |
1.382020E-01 |
| Stage1-vs-Stage4 |
4.684200E-01 |
| Stage2-vs-Stage3 |
5.284200E-01 |
| Stage2-vs-Stage4 |
6.735800E-01 |
| Stage3-vs-Stage4 |
8.873200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.895640E-01 |
| Normal-vs-AfricanAmerican |
8.371400E-01 |
| Normal-vs-Asian |
4.610800E-01 |
| Caucasian-vs-AfricanAmerican |
3.796000E-01 |
| Caucasian-vs-Asian |
1.467550E-01 |
| AfricanAmerican-vs-Asian |
2.867200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.790500E-02 |
| Normal-vs-Female |
2.963400E-01 |
| Male-vs-Female |
2.076600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.163200E-01 |
| Normal-vs-Extreme_Weight |
4.361900E-02 |
| Normal-vs-Obese |
6.021200E-01 |
| Normal-vs-Extreme_Obese |
3.295200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.505200E-01 |
| Normal_Weight-vs-Obese |
8.997200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.955200E-01 |
| Extreme_Weight-vs-Obese |
1.876430E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.444200E-02 |
| Obese-vs-Extreme_Obese |
1.861810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.060230E-01 |
| Normal-vs-Age(41-60Yrs) |
9.812600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.978000E-02 |
| Normal-vs-Age(81-100Yrs) |
9.050200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.638370E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.517500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.864440E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.286500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.515000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.929400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.288030E-01 |
| Normal-VS-Type2 PRCC |
7.918800E-01 |
| Normal-VS-KIRP CIMP |
4.264400E-01 |
| Normal-VS-Unclassified PRCC |
5.924600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.064600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.105800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.024400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.052400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.124600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.910400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.159600E-02 |
| Normal-vs-N1 |
1.341650E-01 |
| Normal-vs-N2 |
9.963000E-01 |
| N0-vs-N1 |
3.427900E-02 |
| N0-vs-N2 |
5.544400E-01 |
| N1-vs-N2 |
5.351400E-01 |
|
|
